March 2, 2024
Rise of Dengue Cases Cause for Concern
October 19, 2023
Health Experts Raise Alarm on Dengue Crisis
Next Generation Dengue Vaccine, other Solutions Presented
Dengue remains to be a major public health problem in the Philippines. But it is reassuring to know that medical science has continued to develop and is working on real solutions, such as new vaccines and other novel and ingenious solutions that address the dengue crisis head on.
Affirming that the full might of Japan, one of the healthiest nations in the world, is behind the Philippines in its fight against dengue: Minister Nihei Daisuke, Minister for Economic Affairs, Embassy of Japan in the Philippines.The inaugural Dengue Forum titled “Addressing the Mosquito in the Room” held last Wednesday, 27 September, aimed to amplify the conversation on dengue as a public health concern in the Philippines. The event was organized by RiseAboveNow Business Consulting Group (RAN-BCG) and was supported by the Embassy of Japan in the Philippines and the Department of Health (DOH).
Between 1 January and 9 September of this year, 125,975 dengue cases were reported across the nation, so far lower compared to cases in the last five years. Since mid-June 2023, 5,000 cases have been registered on an average every week, according to the Department of Health (DOH), Philippines.[1] Despite the plateauing dengue cases, the DOH is not shutting down the possibility of an uptick in cases during the coming the rainy season.
The present impact of dengue was described in the recent dengue forum "Addressing the Mosquito in the Room": The forum gathered a panel of experts from various relevant fields from both relevant government agencies, as well as from the private sector. It aimed to raise the alarm on the already ongoing Dengue Crisis, assess the extent of the burden at this time, map out a multi-sectoral strategy, but perhaps most importantly, to discuss new developments globally on newly introduced solutions that can make a real impact in ending the dengue crisis. This dengue forum was also an opportunity to establish a robust platform for multi-stakeholder collaboration in addressing the dengue situation in the country.
In an official statement, Secretary of the Department of Health (DOH) Teodoro J. Herbosa, MD, emphasized the urgency of the event, and the importance of a holistic approach: “This event carries profound significance as it highlights the importance of a Philippine Collaborative response framework. Dengue is a self-limiting disease, there is currently no definitive therapy or regimen available,” he stressed. With the COVID-19 threat now effectively mitigated, dengue now looms as the one of the most prevalent health concerns in tropical countries such as the Philippines.
Dr. Jose Rene de Grano, MHA, president of the Private Hospitals Association of the Philippines, and pediatrician Dr. Maria Fatima Gualberto of Otsuka Solar Phils. Inc. of Japan shared that dengue was among the leading causes of hospitalization in the post COVID-19 era. While Dr. Kim Patrick Tejano of DOH Disease Prevention and Control Bureau pointed out that dengue was the second biggest health condition in terms of cost for PhilHealth claims nationwide in the last year.
The DOH was represented by Ms. Angelica Garcia Supervising Health Program Officer DOH Epidemiology Bureau (Center), who gave a thorough situation report on dengue in the Philippines for the last 3 years. She is flanked by Lo-Anne Villanueva, Country Manager of Takeda Pharmaceuticals (Right) and Ranielle Mendoza -Founding Partner of Rise Above Now (Left).
Representatives from Local Government Units where dengue incidence was relatively low namely Pasig, Caloocan, Quezon City and Baguio shared their best practices in the area of vector control, or eradication of mosquitoes, emphasizing adherence to the Five S method of controlling dengue:
Search and destroy
Self-protect
Seek consultation
Support fogging
Sustained Hydration
The fact that Dengue is among the leading causes of hospitalization in the Philippines was pointed out by Dr. Jose Rene de Grano, MHA, President Private Hospitals Association of the Philippines, Inc. (Center). He is flanked by Lo-Anne Villanueva, Country Manager of Takeda Pharmaceuticals (Right) and Ranielle Mendoza -Founding Partner of Rise Above Now (Left).
New hope, a LOT of new hope.
However, the most promising news came from the medical experts on hand, who shared that there are in fact new weapons that are available in the war against dengue. Consultant to the DOH and eminent infectious disease authority, Dr. Rontgene Solante fully acknowledged the need for stringent vector control, but he cautioned: “If you focus only on vector control, there is a possibility that it can also reduce herd immunity.” Dr. Solante then shared that there are in fact second-generation dengue vaccines, one that is actually already licensed for use in over 30 countries, including ASEAN neighbors Indonesia and more recently Thailand.
This vaccine are far more advanced than the previous generation. They can be administered safely to people whether or not they have previously had dengue. Numbers are also significantly better than 1st gen vaccine. Solante shared that the TAK003 vaccine already licensed in over 30 countries are 80.2% effective at preventing dengue infection, compared to just 56% for first gen vaccine, it is also 95.4% effective at preventing severe dengue, whereas first generation vaccine had only 91% efficacy.
Dr. Solante shared that the reason behind the superiority of 2nd generation vaccines was that they were engineered on a dengue virus backbone, whereas the 1st generation was built on a Yellow Fever backbone. This is also the reason why 2nd gen vaccines are effective even for those who have never had dengue.
Despite the promise of an effective vaccine, Dr. Solante echoed Secretary Herbosa’s opinion: “Vector control, environmental control, patient education, awareness, even updates in the clinical management are all part of what we call an integrated approach and a vital part of this will be vaccination. So, this is what we call a comprehensive strategy. You have vaccination, as well as vector control.”
TAK003 is manufactured by global, research and development-driven pharmaceutical company Takeda. Takeda was represented at the forum along with three other Japanese firms and no less than Minister for Economic Affairs at the Embassy of Japan in the Philippines, Mr. NIHEI Daisuke who affirmed Japan’s commitment to help ease the global burden of dengue: “We also consider dengue as an international concern, and we are one with the Philippines in your fight against this disease.”
TAK003 vaccine was also recently recommended by the World Health Organization’s Strategic Advisory Group of Experts (SAGE) for introduction in settings with high dengue disease burden and high transmission intensity to maximize impact to public health and that the vaccine introduction should be accompanied by a well-designed communication strategy and community engagement.[2]
New vaccines are not the only new development, Dr. Anna Lisa Ong-Lim, Chief of the Division of Infectious and Tropical Disease at the Philippine General Hospital shared that there is in fact promising news in the area of developing antivirals that could both provide immunity and cure already infected patients. In her presentation, Dr. Ong-Lim shared both the action of the antivirals in development, as well as what stage of trials they have already shown promise in.
While sharing the promise of new developments, Dr. Ong-Lim also talked about simple yet ingenious best practices that have worked worldwide, such as mosquito nets that are used to cover entire small villages. She did reiterate the importance of vaccine, but also pointed out how much more effective these would be if combined with other tactics: “Of course, we know that vaccines are known to be the most efficient approach to be able to target big numbers in these kinds of conditions, but when vaccines are complemented by therapeutic agents, you can even [have] better control.”
Ultimately
with these new developments, it will be possible to bring dengue numbers down
to insignificant levels. To make dengue vaccination widespread though, will
require that every Filipino learn more about this disease and demand that any
and all means be used to end this crisis.
About RANBCG
Rise
Above Now Business Consulting Group (RANBCG) is a management, marketing and
capability-building consulting firm based out of the Philippines specializing
in the healthcare industry. RANBCG, with its 50 years of collective healthcare
experience from its roster of consultants, has been a trusted partner of
pharmaceutical companies in conducting medical conventions, virtual engagement
sessions and physical capability-building workshops for healthcare workers. In
2021, RANBCG was the partner of the Department of Health in holding resiliency
workshops for all healthcare professionals amidst the challenges brought about
by the COVID-19 pandemic.
April 12, 2023
DOH launches multi-sectoral initiative to eradicate tuberculosis
OIC Secretary of Health – Maria Rosario Singh-Vergeire delivers opening remarks on the importance of TB eradication and building a healthy population |
OIC Secretary of Health – Maria Rosario Singh-Vergeire and Department of Interior and Local Government Secretary Benjamin Abalos Jr. present the PAAP-TB document |
FDA Director IV Jesusa Joyce N. Cirunay delivers pledge of support for the elimination of TB in the Philippines |
USAID Philippines Deputy Mission Director Rebekah Eubanks delivers pledge of support for the elimination of TB in the Philippines |
September 23, 2022
Shopee teams up with the Department of Health to push Booster Vaccination
In line with its continuous commitment to help every Filipino increase their protection against COVID-19, Shopee has partnered with the Department of Health (DOH) for the Bakunahang Bayan: PinasLakas Special Vaccination Days campaign from September 26-30, to facilitate the rapid mobilization of COVID-19 vaccination among all eligible populations.
As part of the campaign, a dedicated page will be accessible in-app to educate users on the benefits and importance of vaccination from September 26 to 30, 2022. Local government units (LGUs) across the country are likewise encouraged to include vaccination sites such as schools, malls, plazas, and places of worship where Filipinos can conveniently walk-in to get their COVID-19 booster shot on special vaccination days.
Martin Yu, Director at Shopee Philippines, shared, “It is a great privilege for us to partner with the DOH once again. Through this partnership, we aim to leverage our platform to provide Filipinos with access to accurate and important information about booster shots and COVID-19 vaccination. Through proper education and collaboration, we can work together to fight the spread of COVID-19 in the Philippines.”
This campaign is one of the multiple initiatives that Shopee has launched to support Filipinos in their pre to post vaccination journey. In 2021, Shopee launched the Resbakuna Vaccine Education Campaign, also in partnership with the DOH; the Fully Vaxxed package which incentivized users to complete their vaccination doses; and Vaccination Center Support, which provided food, health essentials, and air coolers to chosen vaccination centers in Makati, Taguig, and Quezon City.
Assistant Secretary Beverly Lorraine Ho, OIC-Undersecretary of the Department of Health shared “Every Filipino plays a vital role in achieving the wall of immunity and protecting every single member of our community, especially the most vulnerable. We are grateful to be partnering with Shopee once more to maximize their platform in effectively reaching, engaging, and educating even more Filipinos on the importance of getting their COVID-19 vaccines and booster doses.”
With the aim of boosting 50 percent of the general population and fully vaccinating 90 percent of the target senior citizens, the Bakunahang Bayan: PinasLakas Special Vaccination Days campaign is expected to educate Filipinos of the benefits the COVID-19 vaccines provide. Through these initiatives, the DOH hopes to encourage even more of our kababayans to receive their booster shots, most especially our senior citizens and the vulnerable population.
From September
26-30, users can learn more about Bakunahang Bayan: PinasLakas Special
Vaccination Days through the dedicated in-app page on the Shopee app.
November 19, 2021
Johnson & Johnson Philippines supports the Department of Health (DOH) in advocating hygiene and physical play to thousands of Filipino Households through the Batang Bida program
June 12, 2021
Shopee and the Department of Health Team Up to Encourage Filipinos to Get Vaccinated
May 27, 2020
Rep. Angelina Tan pushes for mandatory immunization
“We have several initiatives in Congress in relation to the country’s immunization program,” Tan revealed. “We are pushing for the creation of the NITAG, a national immunization advisory board, and we are trying to adopt a school-based immunization program that will benefit our students,” she added.
“Nung lumabas ang bagong ebidensiya na sinubmit sa atin, ang desisyon namin ay ipasok muna sa Health Technology Assessment Center (HTAC). HTAC is reviewing the procurement, which is really the right process. Ngayon po hindi pa lumalabas ang recommendation ng HTAC,” Vergeire revealed.
“According to the WHO, when it comes to pneumococcal vaccination for children, both PCV10 and PCV13 are just as good. The important thing is cost-effectiveness,” Bravo noted.
“We should follow what the WHO says, being experts in their field. If you cannot believe WHO, who will you believe?” she added
“Both vaccines exist. If the health assessment proves that both PCV10 and PCV13 have the same effects, then we need to go through a procurement process that’s open and competitive so the government can save on costs,” Tan said.
“An open, fair, competitive public procurement of NIP vaccines provide the Filipino people the broadest possible options for affordable, quality, and registered vaccines, allowing for potential significant savings to the government while at the same promoting strong public governance.”